SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Papadavid E.)
 

Sökning: WFRF:(Papadavid E.) > EADV Task Force Pru...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005551naa a2200661 4500
001oai:lup.lub.lu.se:222d93a1-dc47-4604-8347-6e8147d7d393
003SwePub
008240530s2024 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:158178858
024a https://lup.lub.lu.se/record/222d93a1-dc47-4604-8347-6e8147d7d3932 URI
024a https://doi.org/10.1111/jdv.201022 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1581788582 URI
040 a (SwePub)lud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
100a Ständer, S.u University Hospital Münster4 aut
2451 0a EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo : Current challenges and future solutions
264 1c 2024
520 a Chronic pruritus (CP) is frequent in general medicine and the most common complaint in general dermatology. The prevalence of CP is expected to rise in the future due to the ageing population. The clinical presentation, underlying aetiology and treatment strategy of CP are heterogeneous. Also, individual treatment aims and physical, psychic and economic burdens of patients might vary. Chronic prurigo (CPG) is the most severe disease in the chronic pruritus spectrum, being associated with long-standing scratch-induced skin lesions and a therapy refractory itch-scratch-cycle. It is thus important to raise disease awareness for CP and CPG in the general public and among decision-makers in the health system. Further, there is a need to support a rational clinical framework to optimize both diagnostics and therapeutics. Currently, there is still a shortcoming regarding approved therapies and understanding CP/CPG as severe medical conditions. Therefore, the EADV Task Force Pruritus decided to publish this white paper based on several consensus meetings. The group consented on the following goals: (a) ensure that CP is recognized as a serious condition, (b) increase public awareness and understanding of CP and CPG as chronic and burdensome diseases that can greatly affect a person's quality of life, (c) clarify that in most cases CP and CPG are non-communicable and not caused by a psychiatric disease, (d) improve the support and treatment given to patients with CP to help them manage their disease and (e) publicize existing therapies including current guidelines. We aim to point to necessary improvements in access and quality of care directed to decision-makers in health policy, among payers and administrations as well as in practical care.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Dermatologi och venereologi0 (SwePub)302042 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Dermatology and Venereal Diseases0 (SwePub)302042 hsv//eng
700a Pereira, M. P.u Charité - University Medicine Berlin,Fraunhofer Institute for Translational Medicine and Pharmacology ITMP4 aut
700a Zeidler, C.u University Hospital Münster4 aut
700a Legat, F. J.u Medical University of Graz4 aut
700a Misery, L.u University Hospital of Brest4 aut
700a Lönndahl, L.u Karolinska Institute4 aut
700a Bewley, A. P.u Barts Health NHS Trust4 aut
700a Brenaut, E.u University Hospital of Brest4 aut
700a Bobko, S.u State Research Center of Dermatovenerology and Cosmetology, Ministry of Healthcare of the Russian Federation4 aut
700a Elberling, J.u Gentofte Hospital4 aut
700a Evers, A. W.M.u Leiden University4 aut
700a Garcovich, S.4 aut
700a Gieler, U.4 aut
700a Gonçalo, M.u University of Coimbra4 aut
700a Kupfer, J.u Justus Liebig University Giessen4 aut
700a Lambert, J.u Antwerp University Hospital4 aut
700a Lvov, A.u Lomonosov Moscow State University4 aut
700a Metz, M.u Charité - University Medicine Berlin,Fraunhofer Institute for Translational Medicine and Pharmacology ITMP4 aut
700a Michenko, A.u Lomonosov Moscow State University4 aut
700a Papadavid, E.u National and Kapodistrian University of Athens4 aut
700a Reich, A.u University of Rzeszów4 aut
700a Savk, E.u Adnan Menderes University4 aut
700a Schneider, G.u University Hospital Münster4 aut
700a Schut, C.u Justus Liebig University Giessen4 aut
700a Serra-Baldrich, E.u Hospital de Sant Pau4 aut
700a Ständer, H. F.4 aut
700a Szepietowski, J. C.u Wrocław Medical University4 aut
700a Wallengren, J.u Lund University,Lunds universitet,Dermatologi och venereologi, Lund,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Dermatology and Venereology (Lund),Section III,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)derm-jwa
700a Weisshaar, E.u Heidelberg University4 aut
700a Augustin, M.u University Medical Center Hamburg-Eppendorf4 aut
710a University Hospital Münsterb Charité - University Medicine Berlin4 org
773t Journal of the European Academy of Dermatology and Venereologyx 0926-9959x 1468-3083
856u http://dx.doi.org/10.1111/jdv.20102x freey FULLTEXT
8564 8u https://lup.lub.lu.se/record/222d93a1-dc47-4604-8347-6e8147d7d393
8564 8u https://doi.org/10.1111/jdv.20102
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:158178858

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy